Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 201 publications
P-selectin binds to complement C4B in human blood plasma.
Journal: Acta biochimica et biophysica Sinica
Published: August 12, 2026
Corrigendum to "Desacetyl-alpha-melanocyte stimulating hormone and alpha-melanocyte stimulating hormone are required to regulate energy balance" [Mol Metab 9 (2018) 207-216/29226825].
Journal: Molecular metabolism
Published: May 07, 2026
Management of Helicobacter pylori-Associated Disease in a Child: Clinical Considerations Beyond a One-Size-Fits-All Approach.
Journal: Gastroenterology
Published: March 31, 2026
Kynurenine: A Promising Structural Motif for Diverse Biological Active Peptides.
Journal: Journal of natural products
Published: February 12, 2026
Introducing CLipPA lipid chemodiversity to enzymatically truncated polymyxin B: a soft drug strategy to combat Gram-negative pathogens.
Journal: RSC medicinal chemistry
Published: December 18, 2025
Early Use of Proton Pump Inhibitors Increases Risk of Upper Respiratory Tract Infections in Children: A Birth Cohort Study.
Journal: Pediatric pulmonology
Published: December 08, 2025
Design, synthesis and biological activity of potential retrometabolic polymyxins via thiol-ene chemistry.
Journal: Chemical communications (Cambridge, England)
Published: December 05, 2025
Loss of FAT1 drives cyclophosphamide resistance in breast cancer via the Wnt/β-Catenin pathway.
Journal: International journal of biological sciences
Published: May 08, 2025
Progress in peptide and protein therapeutics: Challenges and strategies.
Journal: Acta pharmaceutica Sinica. B
Published: April 13, 2025
Lack of association between Helicobacter pylori and pediatric atopy: Evidence from a Latin American multicenter cohort.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 03, 2025
Enhancing the Oral Bioavailability of Glutathione Using Innovative Analogue Approaches.
Journal: Pharmaceutics
Published: January 31, 2025
Comparison between optimized bismuth quadruple therapy and standard clarithromycin-based triple therapy for first-line Helicobacter pylori eradication: a double-blind randomized controlled trial.
Journal: Lancet regional health. Americas
Published: January 15, 2025
Last Updated: 09/26/2026